Table 1.
Results from molecular docking of thirteen different antiviral protease inhibitors. The second column indicates the original viral target of each compound (hepatitis C virus (HCV), human immunodeficiency virus (HIV)).
Inhibitor | Viral Target | Drugbank ID | Vina Scoring (kcal/mol) |
---|---|---|---|
Simeprevir | HCV | DB06290 | −10.0 |
Saquinavir | HIV | DB01232 | −9.3 |
Indinavir | HIV | DB00224 | −8.7 |
Tipranavir | HIV | DB00932 | −8.6 |
Faldaprevir | HCV | DB11808 | −8.4 |
Ritonavir | HIV | DB00503 | −8.1 |
Lopinavir | HIV | DB01601 | −8.1 |
Asunaprevir | HCV | DB11586 | −8.1 |
Atazanavir | HIV | DB01072 | −8.0 |
Nelfinavir | HIV | DB00220 | −7.9 |
Amprenavir | HIV | DB00701 | −7.7 |
Darunavir | HIV | DB01264 | −7.6 |
Fosamprenavir | HIV | DB01319 | −7.2 |